Grants and Contributions

• The Institute of Neurosciences, Mental Health and Addiction (INMHA) will fund an application that is determined to be relevant to the mandate and research priority areas of CIHR-INMHA
o The Institute of Neurosciences, Mental Health and Addiction supports (INMHA) research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use

• The CIHR HIV/AIDS Research Initiative, which is responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or other sexually-transmitted and blood-borne infections (STBBIs) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).
• Research that focuses on key populations identified by the Federal Initiative to Address HIV/AIDS in Canada is highly encouraged.

By engaging thousands of talented young researchers, the programs of the NCE attract and train tomorrow's scientific and business leaders, ensuring that Canada remains competitive in the global economy.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

The specific objectives of this funding opportunity are to:
1.Provide women’s health researchers and trainees with operating funds to perform clinical research;
2.Support capacity building in women’s health among the next generation of health researchers; and
3.Start positioning Canada as a leader in women’s health research.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Arthritis

The Understanding Disease Prevention and Risk Factor Modification Catalyst Grants are expected to:

• increase our understanding of factors that enable individuals to adopt or overlook known disease risk modification strategies;
• expand the evidence and further understanding that can lead to future intervention studies in prevention; and
• develop a knowledge base upon which to nuance evidence-based policy to improve the prevention of manageable diseases.

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

This funding opportunity is expected to:
•Increase Canadian capacity to measure the impact of patient-oriented research in order to demonstrate the extent of health, social and economic benefits realized through patient-oriented research;
•Increase the literature currently available on the impact of patient-oriented research in Canada in order to:
¿Enable summative evaluation and meta-analyses on the impact of patient-oriented research; and,
¿Demonstrate how patient-oriented research compares to other health research approaches in terms of the potential to translate evidence into the health care system.